Lexicon Pharmaceuticals Q3 2026 Results: Net Loss of $14M, Loss Widens
Lexicon Pharmaceuticals reported a net loss of $46.8 million for the nine months ended September 30, 2026, compared to $34.8 million in the prior year period. The company strengthened its balance sheet through common and preferred stock issuances, ending the period with $183.2 million in cash and short-term investments.
- Key figure
- Net loss $14M